SCHEMBL19607239

SCHEMBL19607239

COc1ccc(-[n+]2ccc(-c3cc[n+](-c4ccc(OC)cc4C)cc3C)cc2)c(C)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ BCL2 P10415 1/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ FFAR4 Q5NUL3 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ PTGS2 P35354 1/20 0.33
▸ ALPL P05186 1/20 0.33
▸ ACHE P22303 1/20 0.33
▸ CA12 O43570 1/20 0.32
▸ CA1 P00915 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ CA9 Q16790 1/20 0.32
▸ CYP11B1 P15538 2/20 0.32
▸ CYP11B2 P19099 2/20 0.32
▸ RAPGEF4 Q8WZA2 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ MAPT P10636 2/20 0.32
▸ HPGD P15428 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19601086 0.95 FFAR4 (0.36) L3MBTL1SMN1; SMN2FFAR4PTGS2ACHE
SCHEMBL19607292 0.89 CYP1A1 (0.39) L3MBTL1SMN1; SMN2FFAR4PKMALPL
SCHEMBL19601113 0.84 CYP1A1 (0.35) SMN1; SMN2FFAR4PKMPTGS2ACHE
SCHEMBL19601080 0.81 LMNA (0.31) SMN1; SMN2MAPTHPGDMEN1RAB9A
SCHEMBL19607240 0.77 ACHE (0.44) PTGS2ACHECA12CA1CA2
SCHEMBL19601117 0.75 ACHE (0.37) L3MBTL1SMN1; SMN2PKMPTGS2ACHE
SCHEMBL19607241 0.75 ACHE (0.48) ACHECA12CA1CA2CA9
SCHEMBL19601082 0.74 ACHE (0.43) ACHECA12CA1CA2CA9
SCHEMBL19601088 0.74 ACHE (0.54) ACHECA12CA1CA2CA9
SCHEMBL19601087 0.73 ACHE (0.44) SMN1; SMN2ACHEMAPTMEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10310350-B2 Organic compound, electrochromic compound, and electrochromic element, optical filter, lens unit, imaging device, and window component having same CANON KABUSHIKI KAISHA (JP) 2019-06-04 — — US disclosed
US-20170329195-A1 ORGANIC COMPOUND, ELECTROCHROMIC COMPOUND, AND ELECTROCHROMIC ELEMENT, OPTICAL FILTER, LENS UNIT, IMAGING DEVICE, AND WINDOW COMPONENT HAVING SAME CANON KABUSHIKI KAISHA (JP) 2017-11-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10310350-B2 Organic compound, electrochromic compound, and electrochromic element, optical filter, lens unit, imaging device, and window component having same KCNJ2, KCNH3, KCNN2 L3MBTL1 1091/4885BCL2 2317/4885SMN1; SMN2 4088/4885
US-20170329195-A1 ORGANIC COMPOUND, ELECTROCHROMIC COMPOUND, AND ELECTROCHROMIC ELEMENT, OPTICAL FILTER, LENS UNIT, IMAGING DEVICE, AND WINDOW COMPONENT HAVING SAME KCNJ2, KCNH3, KCNN2 L3MBTL1 1091/4885BCL2 2317/4885SMN1; SMN2 4088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback